In-article:

Covid: Olivier Véran announces the opening of the vaccine booster 4 months after the last dose, teenagers soon affected?


While the government has just announced the possibility of carrying out its vaccine booster four months after its initial schedule, the High Authority for Health recommends a reduction of the time to 3 months … and does not exclude the case of adolescents.

Just a few hours before Christmas Eve, the subject “covid” remains in everyone’s minds and on everyone’s lips. With the record of contaminations known in France since the arrival of the omicron variant on the territory, all solutions are being considered to contain the progression of the disease as much as possible. Faced with this particularly contagious variant which represents the fifth wave of the epidemic and which seems to be more resistant to vaccines, the High Authority for Health has issued new recommendations, which go beyond decisions taken by the executive. Measures which are however not yet topical since Olivier Véran has just specified, this December 24 in the morning, that faced with the spread of the omicron variant, the acceleration of the vaccination schedule with a four month booster after the completion of the first vaccination schedule entered into force as of today. Nearly 7.5 million French people are therefore now eligible for the recall.

A booster dose three months later

But the High Authority for Health recommends going further and proposes to reduce the spacing between the initial vaccination schedule and the booster dose. These recommendations respond to a call from the Directorate General of Health asking to assess the relevance of certain measures. The HAS therefore provides a clear answer to this first hypothesis: yes, given “the current worrying epidemic context”, the administration of a booster dose could be carried out from three months after the primary vaccination. The goal : limit as much as possible the number of new cases of infection and severe forms and avoid the saturation of health establishments “.

For teenagers too?

And this possible booster dose advanced to three months would not only affect adults. On the same basis as adults, the HAS “now recommends the administration of a booster dose in adolescents 12 to 17 years old with an immunodeficiency or severe comorbidity. On the other hand, the press release from the High Authority for Health does not yet open this door to other individuals of this age group, specifying that it “will decide later on the administration of this reminder to all adolescents from 12 to 17 years old” (subject to health pass since September 30) and “The clinical trial conducted by the Pfizer laboratory to assess the efficacy and safety of a booster dose in adolescents is underway”.



Source link -105